“We’re entering into a new era for Liberation Way, one in which the organization’s purpose and mission will guide every action we take,” said Drew Rothermel, J.D, MBA, and new President & CEO of Liberation Way. “One of the most important components of moving forward is to invest in our resources for clinical excellence while building upon the outpatient model that has proven to be very successful in helping people recover from opiate addiction. I am deeply committed to increase the number of people that we can treat with uncompromised ethical standards and compliance to laws to put the health and safety of our patients and workers first.”



Andrew “Drew” Rothermel, J.D, MBA

President & CEO of Liberation Way



Press release:

Fulcrum Equity Partners Acquires Majority Interest in Liberation Behavioral Health; Hires Drew Rothermel as CEO